Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Phenoxymethylpenicillin 125mg/5ml oral solution sugar free
0501011P0AAARAR
|
Phenoxymethylpenicillin (Penicillin V) | Phenoxymethylpenicillin (Penicillin V) | Infections | 9,914 |
|
Aciclovir 400mg dispersible tablets
0503021C0AAAHAH
|
Aciclovir (Systemic) | Aciclovir | Infections | 8,682 |
|
Doxycycline 100mg dispersible tablets sugar free
0501030Z0AAABAB
|
Doxycycline | Doxycycline monohydrate | Infections | 8,395 |
|
Erythromycin ethyl succinate 125mg/5ml susp sugar free
0501050H0AAALAL
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 8,018 |
|
Erythromycin ethyl succinate 125mg/5ml oral suspension
0501050H0AAAAAA
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 7,082 |
|
Ivermectin 3mg tablets
0505060I0AAACAC
|
Ivermectin | Ivermectin | Infections | 6,938 |
|
Tetralysal 300 capsules
0501030L0BBABAB
|
Tetralysal | Lymecycline | Infections | 6,826 |
|
Levofloxacin 500mg tablets
0501120X0AAAAAA
|
Levofloxacin | Levofloxacin | Infections | 6,764 |
|
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free
0501013K0AAADAD
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 6,685 |
|
Dapsone 50mg tablets
0501100H0AAAFAF
|
Dapsone | Dapsone | Infections | 6,348 |
|
Amoxicillin 500mg/5ml oral suspension sugar free
0501013B0AAAVAV
|
Amoxicillin | Amoxicillin | Infections | 6,309 |
|
Nitrofurantoin 25mg/5ml oral suspension sugar free
0501130R0AAACAC
|
Nitrofurantoin | Nitrofurantoin | Infections | 6,054 |
|
Tetracycline 250mg tablets
0501030V0AAAFAF
|
Tetracycline (Systemic) | Tetracycline | Infections | 6,052 |
|
Co-amoxiclav 125mg/31mg/5ml oral suspension
0501013K0AAAHAH
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 5,897 |
|
Monuril 3g granules for oral solution sachets
0501070AEBBADAD
|
Monuril | Fosfomycin trometamol | Infections | 5,736 |
|
Co-amoxiclav 250mg/62mg/5ml oral suspension
0501013K0AAAIAI
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 5,734 |
|
Flucloxacillin 125mg/5ml oral solution sugar free
0501012G0AAAPAP
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 5,632 |
|
Cefalexin 250mg/5ml oral suspension sugar free
0501021L0AAAPAP
|
Cefalexin | Cefalexin | Infections | 5,311 |
|
Doxycycline 40mg modified-release capsules
0501030Z0AAAAAA
|
Doxycycline | Doxycycline monohydrate | Infections | 5,243 |
|
Cefalexin 125mg/5ml oral suspension sugar free
0501021L0AAANAN
|
Cefalexin | Cefalexin | Infections | 4,994 |
|
Clindamycin 300mg capsules
0501060D0AAAMAM
|
Clindamycin hydrochloride (Systemic) | Clindamycin hydrochloride | Infections | 4,901 |
|
Aciclovir 800mg dispersible tablets
0503021C0AAAEAE
|
Aciclovir (Systemic) | Aciclovir | Infections | 4,852 |
|
Ciprofloxacin 750mg tablets
0501120L0AAAJAJ
|
Ciprofloxacin (Systemic) | Ciprofloxacin | Infections | 4,677 |
|
Ofloxacin 400mg tablets
0501120P0AAABAB
|
Ofloxacin (Systemic) | Ofloxacin | Infections | 4,669 |
|
Metronidazole 200mg tablets
0501110C0AAAIAI
|
Metronidazole (Systemic) | Metronidazole | Infections | 3,860 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.